The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia.
Open accessAbstract
High-density lipoprotein (HDL) has been found to neutralize LPS activity in vitro and in animals in vivo. We sought to determine the effects of reconstituted HDL (rHDL) on LPS responsiveness in humans in a double-blind, randomized, placebo-controlled, cross-over study. rHDL, given as a 4-h infusion at 40 mg/kg starting 3.5 h before endotoxin challenge (4 ng/kg), reduced flu-like symptoms during endotoxemia, but did not influence the febrile response. rHDL potently reduced the endotoxin-induced release of TNF, IL-6, and IL-8, while only modestly attenuating the secretion of proinflammatory cytokine inhibitors IL-1ra, soluble TNF receptors and IL-10. In addition, rHDL attenuated LPS-induced changes in leukocyte counts and the enhanced expression of CD11b/CD18 on granulocytes. Importantly, rHDL infusion per se, before LPS administration, was associated with a downregulation of CD14, the main LPS receptor, on monocytes. This effect was biologically relevant, since monocytes isolated from rHDL-treated whole blood showed reduced expression of CD14 and diminished TNF production upon stimulation with LPS. These results suggest that rHDL may inhibit LPS effects in humans in vivo not only by binding and neutralizing LPS but also by reducing CD14 expression on monocytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990) · Science · doi:10.1126/science.1698311 · Cited by 3,987
Receptor-Dependent Mechanisms of Cell Stimulation by Bacterial Endotoxin
Ulevitch, R. J., & Tobias, P. S. (1995) · Annual Review of Immunology · doi:10.1146/annurev.iy.13.040195.002253 · Cited by 1,442
van Deventer, S., Buller, H., ten Cate, J., Aarden, L., Hack, C., & Sturk, A. (1990) · Blood · doi:10.1182/blood.v76.12.2520.2520 · Cited by 851
Self-citationSoluble CD14 participates in the response of cells to lipopolysaccharide.
Frey, E. A., Miller, D. S., Jahr, T. G., Sundan, A., Bazil, V, Espevik, T., Finlay, B. B., & Wright, S. D. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.6.1665 · Cited by 682
CD14: Cell surface receptor and differentiation marker
Ziegler-Heitbrock, H. W. L., & Ulevitch, R. J. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90212-4 · Cited by 584
Arfors, K., Lundberg, C., Lindbom, L., Lundberg, K., Beatty, P., & Harlan, J. (1987) · Blood · doi:10.1182/blood.v69.1.338.338 · Cited by 524
In vivo protection against endotoxin by plasma high density lipoprotein.
Levine, D. M., Parker, T. S., Donnelly, T. M., Walsh, A., & Rubin, A. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.12040 · Cited by 485
Wurfel, M. M., Kunitake, S. T., Lichenstein, H., Kane, J. P., & Wright, S. D. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.1025 · Cited by 442
Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes
Bazil, V, & Strominger, J. L. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.5.1567 · Cited by 424
Lipopolysaccharide Binding Protein-mediated Complexation of Lipopolysaccharide with Soluble CD14
Tobias, P. S., Soldau, K., Gegner, J. A., Mintz, D., & Ulevitch, R. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10482 · Cited by 324
Harris, H. W., Grunfeld, C., Feingold, K. R., & Rapp, J. H. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114765 · Cited by 320
Wright, S. D., Ramos, R. A., Hermanowski-Vosatka, A., Rockwell, P., & Detmers, P. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.5.1281 · Cited by 285
Wurfel, M. M., Hailman, E., & Wright, S. D. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1743 · Cited by 267
Parker, T. S., Levine, D. M., Chang, J. C., Laxer, J., Coffin, C. C., & Rubin, A. L. (1995) · Infection and Immunity · doi:10.1128/iai.63.1.253-258.1995 · Cited by 211
Role for circulating lipoproteins in protection from endotoxin toxicity
Feingold, K. R., Funk, J. L., Moser, A. H., Shigenaga, J. K., Rapp, J. H., & Grunfeld, C. (1995) · Infection and Immunity · doi:10.1128/iai.63.5.2041-2046.1995 · Cited by 209
In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins
Emancipator, K., Csákó, G., & Elin, R. J. (1992) · Infection and Immunity · doi:10.1128/iai.60.2.596-601.1992 · Cited by 156
Inhibition of endotoxin-induced activation of human monocytes by human lipoproteins
Flegel, W. A., Wolpl, A., Männel, D. N., & Northoff, H. (1989) · Infection and Immunity · doi:10.1128/iai.57.7.2237-2245.1989 · Cited by 148
Lerch, P. G., Förtsch, V., Hodler, G., & Bolli, R. (1996) · Vox Sanguinis · doi:10.1046/j.1423-0410.1996.7130155.x · Cited by 130
Self-citationMöhlen, M. A. M. V. D., Kimmings, A. N., Wedel, N. I., Mevissen, M. L. C. M., Jansen, J., Friedmann, N., Lorenz, T. J., Nelson, B. J., White, M., Bauer, R. J., et al. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/172.1.144 · Cited by 120
Modulation of Endotoxic Activity of Lipopolysaccharide by High-Density Lipoprotein
Baumberger, C., Ulevitch, R. J., & Dayer, J. M. (2008) · Pathobiology · doi:10.1159/000163681 · Cited by 96
Lipopolysaccharide induces up‐regulation of CD14 molecule on monocytes in human whole blood
Marchant, A., Duchow, J., Delville, J., & Goldman, M. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220650 · Cited by 94
The protective effect of serum lipoproteins against bacterial lipopolysaccharide.
Read, T. E., Harris, H. W., Grünfeld, C., et al. (1993) · PubMed · Cited by 74
Hubsch, A. P., Fs, P., Pg, L., & Doran, J. E. (1993) · PubMed · Cited by 69
Self-citationEichacker, P. Q., Farese, A. M., Hoffman, W. D., Banks, S. M., Mouginis, T. L., Richmond, S., Kuo, G. C., MacVittie, T. J., & Natanson, C. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.5.1023 · Cited by 56
Cué, J. I., DiPiro, J. T., Brunner, L. J., Doran, J. E., Blankenship, M. E., Mansberger, A. R., & Hawkins, M. L. (1994) · Archives of Surgery · doi:10.1001/archsurg.1994.01420260089012 · Cited by 43
Self-citationMészáros, K., Aberle, S., White, M., & Parent, J. B. (1995) · Infection and Immunity · doi:10.1128/iai.63.1.363-365.1995 · Cited by 40
Optimalization of a chromogenic assay for endotoxin in blood.
Sturk, A., Joop, K., ten Cate, J. W., & Thomas, L. L. M. (1985) · PubMed · Cited by 32
Cited by
Khovidhunkit, W., Kim, M.-S., Memon, R. A., Shigenaga, J. K., Moser, A. H., Feingold, K. R., & Grunfeld, C. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r300019-jlr200 · Cited by 1,481
Cholesterol, inflammation and innate immunity.
Tall, A. R., & Yvan-Charvet, L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3793 · Cited by 1,479
Dietary lipids, gut microbiota and lipid metabolism
Schoeler, M., & Caesar, R. (2019) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-019-09512-0 · Cited by 1,163
Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock
Van Amersfoort, E. S., Van Berkel, T. J. C., & Kuiper, J. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.3.379-414.2003 · Cited by 750
Role of HDL, ABCA1, and ABCG1 Transporters in Cholesterol Efflux and Immune Responses
Yvan-Charvet, L., Wang, N., & Tall, A. R. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179283 · Cited by 680
Metadata
- Authors
- Pajkrt, D., Doran, J. E., Koster, F., Lerch, P. G., Arnet, B., van der Poll, T., ten Cate, J. W., & van Deventer, S. J.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1996-11-01
- Volume
- 184
- Issue
- 5
- Pages
- 1601-1608
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2158092179
- Cited by
- 390
- References
- 27
- FWCI
- 4.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.